tiprankstipranks
Trending News
More News >

Senzime AB Approves Directed Share Issue to Adam Dahlberg

Story Highlights
Senzime AB Approves Directed Share Issue to Adam Dahlberg

Don’t Miss TipRanks’ Half-Year Sale

Senzime AB ( (SE:SEZI) ) has issued an announcement.

Senzime AB held an extraordinary general meeting where shareholders unanimously approved a directed share issue, allowing Adam Dahlberg to subscribe for up to 700,000 new shares at SEK 4.60 each. This decision will increase the company’s share capital by a maximum of SEK 87,500, potentially impacting its financial structure and market positioning.

More about Senzime AB

Senzime is a leading medical device company established in 1999, specializing in precision-based monitoring systems that enhance perioperative patient safety. Their flagship product, the TetraGraph® system, is widely used for neuromuscular transmission monitoring during surgery. Headquartered in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market and the US OTCQX Market.

YTD Price Performance: -7.09%

Average Trading Volume: 326,030

Current Market Cap: SEK799.8M

For detailed information about SEZI stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1